Send feedback

ERBB2 p.Asp502=

c.1506C>T · rs752759368 · VCV2170355

Likely benign Single submitter
Classification
Likely benign
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
gnomAD v4.1
Rare
ultra-rare (popmax 0.0164%, mid)

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -10GERP -5.3
Overall
CADD0.788PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0164% Middle Eastern · 1/6,082 alleles
Filtering AF 0.00723% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0055%
Overall 0.00311% 50/1,609,032 alleles · ultra-rare
Ancestry group Frequency 1 in
Middle Easterngrpmax 0.0164% 6,082
African / African-American 0.0133% 7,494
Remaining individualsnot grpmax-eligible 0.0112% 8,923
Admixed American 0.01% 9,997
European (non-Finnish) 0.00212% 47,197
South Asian 0.0011% 91,054

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
ERBB2
Protein
p.Asp502=
Coding
c.1506C>T
MANE Select
NM_004448
dbSNP
rs752759368
Type
single nucleotide variant
Location
chr17:39715932 (GRCh38)
Gene constraint
LOEUF 0.518 · pLI 0.06 (gnomAD)
Structure
AlphaFold pLDDT 74.65 · 63 PDB
Residue 502
an α-helix; a disulfide bond
Full ERBB2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/erbb2-p-asp502 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown